4.3 Article

Highly Efficient Derivation of Skeletal Myotubes from Human Embryonic Stem Cells

期刊

STEM CELL REVIEWS AND REPORTS
卷 8, 期 4, 页码 1109-1119

出版社

SPRINGER
DOI: 10.1007/s12015-012-9413-4

关键词

Human embryonic stem cells; Skeletal myotube; Directed differentiation; Muscle development; Tet-on; MyoD

资金

  1. Ministry of Science and Technology of China [2011CB965101, 2011CBA01001, 2012AA020503, 2011AA020108]
  2. National Science Fund for Distinguished Young Scholars [31025016]
  3. National Natural Science Foundation of China [30971682, 30901019, 31271586]
  4. Fundamental Research Funds for the Central Universities
  5. Key Construction Program of the National 985 Project [118000+193411801/006]
  6. Research Fund for the Doctoral Program of Higher Education of China [20110101110098]

向作者/读者索取更多资源

Human embryonic stem cells (hESCs) are a promising model for the research of embryonic development and regenerative medicine. Since the first hESC line was established, many researchers have shown that pluripotent hESCs can be directed into many types of functional adult cells in culture. However, most of the reported methods have induced differentiation through the alteration of growth factors in the culture medium. These methods are time consuming; moreover, it is difficult to obtain a pure population of the desired cells because of the low efficiency of induction. In this study, we used a lentiviral-based inducible gene-expression system in hESCs to control the ectopic expression of MyoD, which is an essential transcription factor in skeletal muscle development. The induction of MyoD can efficiently direct the pluripotent hESCs into mesoderm in 24 h. The cells then become proliferated myoblasts and finally form multinucleated myotubes in vitro. The whole procedure took about 10 days, with an induction efficiency of over 90 %. To our knowledge, this is the first time that hESCs have been induced into terminally differentiated cells with only one factor. In the future, these results could be a potential resource for cell therapy for diseases of muscle dysfunction.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据